PEDIATRICS Vol. 94 No. 6 December 1994, pp. 832-840
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sandberg, D. E.
Right arrow Articles by Campos, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sandberg, D. E.
Right arrow Articles by Campos, S. P.

Short Stature: A Psychosocial Burden Requiring Growth Hormone Therapy?

David E. Sandberg PhD1, Amy E. Brook BA1, and Susana P. Campos MD2

1 Division of Child and Adolescent Psychiatry, Departments of Psychiatry and Pediatrics, State University of New York at Buffalo, Buffalo, New York
2 Division of Endocrinology, Children's Hospital of Buffalo, Departments of Pediatrics, State University of New York at Buffalo, Buffalo, New York

Background. Changes in the diagnosis of endocrine-based growth disorders and the advent of biosynthetic growth hormone have altered the long-standing policy of treating only those individuals with "classic" growth hormone deficiency. One justification for treating short children is to improve their psychosocial adaptation. The present investigation assessed the positive and negative behavioral adaptation, self-perceptions of domain-specific competencies, and global self-worth of a large, diagnostically heterogeneous sample of children and adolescents referred to pediatric endocrinologists for a growth evaluation.

Methods. All patients seen in a pediatric endocrine clinic (180 boys and 78 girls; 4 to 18 years) with a height at the fifth percentile or lower were included. Parents of all participating children completed the Child Behavior Checklist. Patients 8 years and older completed the Self-Perception Profile and those 11 years and older, in addition, completed the Youth Self Report. Short-stature (SS) subjects were compared with normative and psychiatric samples.

Results. The SS boys were described by parents as being significantly less socially competent and showing more behavioral and emotional problems than a normative sample selected for mental health. However, they were significantly more socially competent and showed fewer psychopathologic symptoms than a psychiatric referred sample of comparable age. The SS boys described themselves as less socially active but did not report more behavior disturbance than the normative sample. The SS boys' self-perceptions of domain-specific competencies and global self-worth were comparable to a normative comparison group with the exception that older subjects (13 years or older) described their athletic abilities more positively and their work competence more negatively. The SS girls were, with few exceptions, indistinguishable from the normal comparison groups on both parent- and self-report measures of social competency and behavior disturbance. Younger SS girls (ages 8 to 12 years) described their athletic competence and behavioral conduct more positively than the comparison group on the self-esteem questionnaire. Patient height deficit was unrelated to scores on the three questionnaires. Finally, no statistically significant differences in psychosocial functioning were detected between children with "normal-variant" SS and those with pathologic growth disorders.

Conclusions. Short-stature girls show more adaptive psychosocial functioning than SS boys. In either sex, SS does not appear to be associated with clinically significant psychosocial morbidity. Severity of the height deficit does not correlate with the level of behavioral adaptation. These observations challenge the justification of providing growth hormone therapy for all short children to improve their psychosocial functioning.

Submitted on September 2, 1993
Accepted on March 23, 1994




This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
L. D Voss
Is short stature a problem? The psychological view
Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S39 - S45.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
H Visser-van Balen, G Sinnema, and R Geenen
Growing up with idiopathic short stature: psychosocial development and hormone treatment; a critical review.
Arch. Dis. Child., May 1, 2006; 91(5): 433 - 439.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
S. F. Kemp
Height and Social Adjustment
Pediatrics, February 1, 2005; 115(2): 515 - 516.
[Full Text] [PDF]

Home page
 PediatricsHome page
W. M. Bukowski, R. B. Noll, C. Fung, and D. E. Sandberg
Height and Social Adjustment: In Reply
Pediatrics, February 1, 2005; 115(2): 516 - 517.
[Full Text] [PDF]

Home page
 PediatricsHome page
D. E. Sandberg, W. M. Bukowski, C. M. Fung, and R. B. Noll
Height and Social Adjustment: Are Extremes a Cause for Concern and Action?
Pediatrics, September 1, 2004; 114(3): 744 - 750.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
P. A. Lee, J. W. Kendig, and J. R. Kerrigan
Persistent Short Stature, Other Potential Outcomes, and the Effect of Growth Hormone Treatment in Children Who Are Born Small for Gestational Age
Pediatrics, July 1, 2003; 112(1): 150 - 162.
[Full Text] [PDF]

Home page
 NEJMHome page
M. M. Lee
Is Treatment with a Luteinizing Hormone-Releasing Hormone Agonist Justified in Short Adolescents?
N. Engl. J. Med., March 6, 2003; 348(10): 942 - 945.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. M. Wit and L. T. M. Rekers-Mombarg
Final Height Gain by GH Therapy in Children with Idiopathic Short Stature Is Dose Dependent
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 604 - 611.
[Abstract] [Full Text] [PDF]

Home page
 The Journal of School NursingHome page
J. K. Williams, A. M. McCarthy, H. Bragadottir, and D. Reed
School Nurses' Experiences, Concerns, and Knowledge of Growth Disorders in Children: Development of a Monograph
The Journal of School Nursing, February 1, 2002; 18(1): 25 - 32.
[Abstract] [PDF]

Home page
 Endocr. Rev.Home page
W. M. Drake, S. J. Howell, J. P. Monson, and S. M. Shalet
Optimizing GH Therapy in Adults and Children
Endocr. Rev., August 1, 2001; 22(4): 425 - 450.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
C G D BROOK;, C. J H KELNAR;, and P. BETTS
Controversy: Which children should receive growth hormone treatment
Arch. Dis. Child., August 1, 2000; 83(2): 176 - 178.
[Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
L. D Voss
Short but normal
Arch. Dis. Child., October 1, 1999; 81(4): 370 - 371.
[Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Lagrou, D. Xhrouet-Heinrichs, C. Heinrichs, M. Craen, J.-P. Chanoine, P. Malvaux, and J.-P. Bourguignon
Age-Related Perception of Stature, Acceptance of Therapy, and Psychosocial Functioning in Human Growth Hormone-Treated Girls with Turner's Syndrome
J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1494 - 1501.
[Abstract] [Full Text]

Home page
 BMJHome page
A B. Downie, J. Mulligan, R. J Stratford, P. R Betts, and L. D Voss
Are short normal children at a disadvantage? The Wessex growth study
BMJ, January 11, 1997; 314(7074): 97 - 97.
[Abstract] [Full Text]